Adrenaline Presentation
Adrenaline Presentation
Adrenaline Presentation
The amino acid tyrosine is transported into the sympathetic nerve axon
Tyrosine is converted to DOPA by tyrosine hydroxylase ( rate limiting step for norepinephrine synthesis)
DOPA is converted to dopamine by DOPA decarboxylase
Dopamine is transported into vesicles then converted to norepinephrine by dopamine beta-hydroxylase.
This transport into vesicles is blocked by the drug reserpine.
An action potential traveling down the axon depolarises the membrane and causes calcium to enter the
axon.
Increased intracellular calcium causes the vesicles to migrate to the axonal membrane and fuse with
the membrane, which permits the norepinephrine to diffuse out of the vesicle into the extracellular
space
The norepinephrine binds to the post-synaptic receptors i.e the adrenoceptors and simulates the
effector organ response.
NOTE: epinephrine is not the primary neurotransmitter for the sympathetic nervous system, it is the
primary hormone, norepinephrine is the primary neurotransmitter.
Norepinephrine and Epinephrine
Removal and Metabolism
The binding of NE to its receptor depends on the concentration of NE in the vicinity of the
receptor.
If the nerve stops releasing NE, then the NE concentration in the junctional cleft will
decrease and NE will leave the receptor
There are several mechanisms by which the norepinephrine is removed from the
intercellular (junctional) space and therefore from the postjunctional receptor:
1.Most (~90%) of the NE is transported back into the nerve terminal by a neuronal
reuptake transport system i.e norepinephrine autoreceptors. This transporter is blocked
by cocaine; therefore, cocaine increases junctional NE concentrations by blocking its
reuptake and subsequent metabolism. (This is a major mechanism by which cocaine
stimulates cardiac function and raises blood pressure.)
2. Some of the junctional NE diffuses into capillaries and is carried out of the tissue by the
circulation. Therefore, high levels of sympathetic activation in the body increase the
plasma concentration of NE and its metabolites.
3.Some of the junctional NE is metabolized within the extracellular space before reaching
the capillaries.
4.A small amount of NE (~5%) is taken up by the postjunctional tissue (termed
"extraneuronal uptake") and metabolized.
NE and epinephrine are metabolized by the enzymes catechol-O-
methytransferase (COMT) and monoamine oxidase (MAO). The final product of
these pathways is vanillylmandelic acid (VMA). This final product, along with
its precursors normetanephrine and metanephrine, is measured in urine and
plasma in the diagnosis of pheochromocytoma, which can cause severe
hypertension and cardiac arrhythmias.